AG˹ٷ

STOCK TITAN

[8-K] TransMedics Group, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Orrstown Financial Services (ORRF) President & CEO Thomas R. Quinn Jr. has filed a Form 4 for a 28 Jul 2025 transaction. A Code F line shows 6,598 restricted shares disposed at $34.55 (� $228 k) to cover withholding taxes triggered by vesting; this is not an open-market sale.

Post-transaction, Quinn still holds 8,918 time-vested restricted shares, 30,116 performance-based RSUs, and 86,453 common shares (62,621 jointly with his spouse)—roughly 125 k shares in total. No derivative securities were traded or granted. The event is routine and does not materially alter insider alignment with shareholders.

Thomas R. Quinn Jr., Presidente e CEO di Orrstown Financial Services (ORRF), ha presentato un Modulo 4 relativo a una transazione del 28 luglio 2025. Una riga Codice F indica la cessione di 6.598 azioni vincolate a 34,55 $ ciascuna (circa 228 mila $) per coprire le imposte trattenute generate dal vesting; non si tratta di una vendita sul mercato aperto.

Dopo la transazione, Quinn detiene ancora 8.918 azioni vincolate con scadenza temporale, 30.116 RSU basate sulle performance e 86.453 azioni ordinarie (di cui 62.621 in comproprietà con il coniuge), per un totale di circa 125.000 azioni. Non sono stati negoziati né assegnati strumenti derivati. L’evento è di routine e non modifica sostanzialmente l’allineamento degli insider con gli azionisti.

Thomas R. Quinn Jr., Presidente y CEO de Orrstown Financial Services (ORRF), ha presentado un Formulario 4 para una transacción del 28 de julio de 2025. Una línea con Código F muestra la disposición de 6.598 acciones restringidas a $34.55 cada una (aproximadamente $228 mil) para cubrir impuestos retenidos derivados del vesting; esto no es una venta en el mercado abierto.

Después de la transacción, Quinn aún posee 8.918 acciones restringidas con vesting temporal, 30.116 RSU basadas en desempeño y 86.453 acciones comunes (62.621 en conjunto con su cónyuge), sumando alrededor de 125 mil acciones en total. No se negociaron ni otorgaron valores derivados. El evento es rutinario y no altera significativamente la alineación del insider con los accionistas.

Orrstown Financial Services(ORRF)� 사장 � CEO� Thomas R. Quinn Jr.가 2025� 7� 28� 거래� 대� Form 4� 제출했습니다. 코드 F 항목에는 베스팅으� 인해 발생� 원천징수세를 충당하기 위해 6,598� 제한 주식� 주당 $34.55 (� 22� 8� 달러)� 처분되었음을 나타내며, 이는 공개 시장 판매가 아닙니다.

거래 � Quinn은 여전� 8,918주의 시간 기반 제한 주식, 30,116주의 성과 기반 RSU, 그리� 86,453주의 보통� (그중 62,621주는 배우자와 공동 보유)� 보유하고 있어 � � 12� 5� �� 달합니다. 파생 증권� 거래� 부여는 없었습니�. 이번 사건은 일상적인 것으� 내부자와 주주 간의 정렬� 실질적인 변화를 주지 않습니다.

Thomas R. Quinn Jr., président et PDG d'Orrstown Financial Services (ORRF), a déposé un formulaire 4 pour une transaction datée du 28 juillet 2025. Une ligne Code F indique la cession de 6 598 actions restreintes à 34,55 $ chacune (environ 228 000 $) pour couvrir les impôts retenus à la source déclenchés par l'acquisition des droits ; il ne s'agit pas d'une vente sur le marché ouvert.

Après la transaction, Quinn détient encore 8 918 actions restreintes à acquisition temporelle, 30 116 RSU basées sur la performance et 86 453 actions ordinaires (dont 62 621 en commun avec son conjoint), soit environ 125 000 actions au total. Aucun titre dérivé n’a été négocié ni attribué. L’événement est routinier et ne modifie pas significativement l’alignement des initiés avec les actionnaires.

Thomas R. Quinn Jr., Präsident und CEO von Orrstown Financial Services (ORRF), hat ein Formular 4 für eine Transaktion am 28. Juli 2025 eingereicht. Eine Code F-Zeile zeigt die Veräußerung von 6.598 eingeschränkten Aktien zu je 34,55 $ (ca. 228.000 $), um einbehaltene Steuern zu begleichen, die durch das Vesting ausgelöst wurden; dies ist kein Verkauf am offenen Markt.

Nach der Transaktion hält Quinn weiterhin 8.918 zeitlich beschränkte Aktien, 30.116 leistungsbasierte RSUs und 86.453 Stammaktien (davon 62.621 gemeinsam mit seinem Ehepartner) � insgesamt etwa 125.000 Aktien. Es wurden keine Derivate gehandelt oder gewährt. Das Ereignis ist routinemäßig und verändert die Insider-Ausrichtung mit den Aktionären nicht wesentlich.

Positive
  • CEO retains roughly 125 k shares, continuing a meaningful ownership stake that aligns management interests with shareholders
Negative
  • 6,598 shares were surrendered at $34.55, reducing direct holdings, though transaction was tax-related and not discretionary

Insights

TL;DR: Routine tax-withholding disposal; CEO retains sizeable stake, neutral for valuation.

The Code F classification indicates the shares were surrendered solely to satisfy payroll-tax obligations on vested awards. At � $228 k, the disposal is <1 % of the CEO’s total holdings and is not an open-market signal. No options were exercised, and aggregate insider ownership remains robust, supporting continued alignment. Market impact should be negligible unless compounded by further sales.

TL;DR: Governance-neutral filing; maintains strong insider ownership posture.

Quinn’s ownership after the event still exceeds 2 % of outstanding shares (estimate), well above typical alignment thresholds. Code F disposals are viewed as administrative rather than discretionary, so no governance red flags arise. Investors should monitor future Form 4s for pattern changes, but this single filing is procedurally routine.

Thomas R. Quinn Jr., Presidente e CEO di Orrstown Financial Services (ORRF), ha presentato un Modulo 4 relativo a una transazione del 28 luglio 2025. Una riga Codice F indica la cessione di 6.598 azioni vincolate a 34,55 $ ciascuna (circa 228 mila $) per coprire le imposte trattenute generate dal vesting; non si tratta di una vendita sul mercato aperto.

Dopo la transazione, Quinn detiene ancora 8.918 azioni vincolate con scadenza temporale, 30.116 RSU basate sulle performance e 86.453 azioni ordinarie (di cui 62.621 in comproprietà con il coniuge), per un totale di circa 125.000 azioni. Non sono stati negoziati né assegnati strumenti derivati. L’evento è di routine e non modifica sostanzialmente l’allineamento degli insider con gli azionisti.

Thomas R. Quinn Jr., Presidente y CEO de Orrstown Financial Services (ORRF), ha presentado un Formulario 4 para una transacción del 28 de julio de 2025. Una línea con Código F muestra la disposición de 6.598 acciones restringidas a $34.55 cada una (aproximadamente $228 mil) para cubrir impuestos retenidos derivados del vesting; esto no es una venta en el mercado abierto.

Después de la transacción, Quinn aún posee 8.918 acciones restringidas con vesting temporal, 30.116 RSU basadas en desempeño y 86.453 acciones comunes (62.621 en conjunto con su cónyuge), sumando alrededor de 125 mil acciones en total. No se negociaron ni otorgaron valores derivados. El evento es rutinario y no altera significativamente la alineación del insider con los accionistas.

Orrstown Financial Services(ORRF)� 사장 � CEO� Thomas R. Quinn Jr.가 2025� 7� 28� 거래� 대� Form 4� 제출했습니다. 코드 F 항목에는 베스팅으� 인해 발생� 원천징수세를 충당하기 위해 6,598� 제한 주식� 주당 $34.55 (� 22� 8� 달러)� 처분되었음을 나타내며, 이는 공개 시장 판매가 아닙니다.

거래 � Quinn은 여전� 8,918주의 시간 기반 제한 주식, 30,116주의 성과 기반 RSU, 그리� 86,453주의 보통� (그중 62,621주는 배우자와 공동 보유)� 보유하고 있어 � � 12� 5� �� 달합니다. 파생 증권� 거래� 부여는 없었습니�. 이번 사건은 일상적인 것으� 내부자와 주주 간의 정렬� 실질적인 변화를 주지 않습니다.

Thomas R. Quinn Jr., président et PDG d'Orrstown Financial Services (ORRF), a déposé un formulaire 4 pour une transaction datée du 28 juillet 2025. Une ligne Code F indique la cession de 6 598 actions restreintes à 34,55 $ chacune (environ 228 000 $) pour couvrir les impôts retenus à la source déclenchés par l'acquisition des droits ; il ne s'agit pas d'une vente sur le marché ouvert.

Après la transaction, Quinn détient encore 8 918 actions restreintes à acquisition temporelle, 30 116 RSU basées sur la performance et 86 453 actions ordinaires (dont 62 621 en commun avec son conjoint), soit environ 125 000 actions au total. Aucun titre dérivé n’a été négocié ni attribué. L’événement est routinier et ne modifie pas significativement l’alignement des initiés avec les actionnaires.

Thomas R. Quinn Jr., Präsident und CEO von Orrstown Financial Services (ORRF), hat ein Formular 4 für eine Transaktion am 28. Juli 2025 eingereicht. Eine Code F-Zeile zeigt die Veräußerung von 6.598 eingeschränkten Aktien zu je 34,55 $ (ca. 228.000 $), um einbehaltene Steuern zu begleichen, die durch das Vesting ausgelöst wurden; dies ist kein Verkauf am offenen Markt.

Nach der Transaktion hält Quinn weiterhin 8.918 zeitlich beschränkte Aktien, 30.116 leistungsbasierte RSUs und 86.453 Stammaktien (davon 62.621 gemeinsam mit seinem Ehepartner) � insgesamt etwa 125.000 Aktien. Es wurden keine Derivate gehandelt oder gewährt. Das Ereignis ist routinemäßig und verändert die Insider-Ausrichtung mit den Aktionären nicht wesentlich.

0001756262false00017562622025-07-302025-07-30

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 30, 2025

 

 

TransMedics Group, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Massachusetts

001-38891

83-2181531

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

200 Minuteman Road

 

Andover, Massachusetts

 

01810

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (978) 552-0900

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, no par value per share

 

TMDX

 

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

Item 2.02 Results of Operations and Financial Condition.

On July 30, 2025, TransMedics Group, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended June 30, 2025. A copy of this press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

The information in this Form 8-K (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing by the Company, under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No.

 

Description

99.1

Press release issued by TransMedics Group, Inc. on July 30, 2025

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

TRANSMEDICS GROUP, INC.

 

 

 

 

Date:

July 30, 2025

By:

/s/ Gerardo Hernandez

 

 

 

Name: Gerardo Hernandez
Title: Chief Financial Officer and Treasurer

 

 


FAQ

How many ORRF shares did CEO Thomas R. Quinn Jr. dispose of?

He surrendered 6,598 restricted shares on 28 Jul 2025.

What does Code F mean on a Form 4 filing?

Code F signifies shares withheld or delivered solely to pay taxes owed on vested equity, not an open-market sale.

How many Orrstown Financial shares does the CEO own after the transaction?

Quinn still owns about 125 k shares in total: 8,918 restricted, 30,116 RSUs, and 86,453 common shares.

Was any derivative security activity reported?

No; the filing shows no options, warrants, or other derivative transactions.

Is this Form 4 likely to impact ORRF stock price?

Given the routine, tax-related nature and small size relative to holdings, material price impact is unlikely.
Transmedics Group

NASDAQ:TMDX

TMDX Rankings

TMDX Latest News

TMDX Latest SEC Filings

TMDX Stock Data

3.64B
32.81M
3.5%
115.88%
27.72%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
United States
ANDOVER